HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Title
HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 12, Issue -, Pages 2285-2292
Publisher
Dove Medical Press Ltd.
Online
2018-07-23
DOI
10.2147/dddt.s169734

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started